Mavrilimumab to Reduce Progression of Acute Respiratory Failure in COVID-19 Pneumonia and Systemic Hyper-inflammation
Clinical trial NCT04492514 · COMPLETED
Trial details
- NCT number
- NCT04492514
- Sponsor
- Kristin Hudock
- Status
- COMPLETED
- Phase
- Phase 2
- Study type
- INTERVENTIONAL
- Start date
- 2020-05-20
- Primary completion
- 2020-11-16
- Enrollment
- 1
Track trials programmatically
Sponsors, conditions and status changes through the Atlas API.